 |
Innovation or Stagnation: Challenge and Opportunity on the Critical Path to New Medical Products
16.09.2004
This report provides the Food and Drug Administration's (FDA's) analysis of the pipeline problem -- the recent slowdown, instead of the expected acceleration, in innovative medical therapies reaching patients.


|